Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Petr Kuzmič

2PUBLICATIONS

33CO-AUTHORS

Molecular targetsGene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jun 04, 2025

STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20-Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models.

Raymond A Pagliarini, Jack A Henderson, Benjamin C Milgram

|Mar 30, 2024

Preclinical evaluation of the SARS-CoV-2 M<sup>pro</sup> inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir.

Xiaoxin Chen, Xiaodong Huang, Qinhai Ma

Pageof 1

Frequent Collaborators

1 joint publications

Xiaodong Huang

1 joint publications

Jinxin Xu

1 joint publications

Jinsong Liu

1 joint publications

Tianyu Zhang

1 joint publications

James Spencer

1 joint publications

Wenbin Deng

1 joint publications

Shu-Hui Chen

1 joint publications

Nanshan Zhong

1 joint publications

Xiaoli Xiong

1 joint publications

Zifeng Yang

Frequent Collaborators

1 joint publications

Xiaodong Huang

1 joint publications

Jinxin Xu

1 joint publications

Jinsong Liu

1 joint publications

Tianyu Zhang

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

See more related videos